Strategic · Biotech
General Proximity: Strategic
Develops induced proximity medicines targeting undruggable proteins across oncology and cardiometabolic disease
Funding history
Strategic · This round$20M
Loading rounds…
Develops induced proximity medicines targeting undruggable proteins across oncology and cardiometabolic disease